Symptomatic neuroma development following en bloc resection of skeletal and soft tissue tumors: A retrospective analysis of 331 cases

Abstract

Background: Although symptomatic neuroma formation has been described in other patient populations, these data have not been studied in patients undergoing resection of musculoskeletal tumors. This study aimed to characterize the incidence and risk factors of symptomatic neuroma formation following en bloc resection in this population. Methods: The authors retrospectively reviewed adults undergoing en bloc resections for musculoskeletal tumors at a high-volume sarcoma center from 2014 to 2019. The authors included en bloc resections for an oncologic indication and excluded non-en bloc resections, primary amputations, and patients with insufficient follow-up. Data are provided as descriptive statistics, and multivariable regression modeling was performed. Results: The authors included 231 patients undergoing 331 en bloc resections (female, 46%; mean age, 52 years). Nerve transection was documented in 87 resections (26%). There were 81 symptomatic neuromas (25%) meeting criteria of Tinel sign or pain on examination and neuropathy in the distribution of suspected nerve injury. Factors associated with symptomatic neuroma formation included age 18 to 39 [adjusted OR (aOR), 3.6; 95% CI, 1.5 to 8.4; P < 0.01] and 40 to 64 (aOR, 2.2; 95% CI, 1.1 to 4.6; P = 0.04), multiple resections (aOR, 3.2; 95% CI, 1.7 to 5.9; P < 0.001), preoperative neuromodulator requirement (aOR, 2.7; 95% CI, 1.2 to 6.0; P = 0.01), and resection of fascia or muscle (aOR, 0.5; 95% CI, 0.3 to 1.0; P = 0.045). Conclusion:The authors' results highlight the importance of adequate preoperative optimization of pain control and intraoperative prophylaxis for neuroma prevention following en bloc resection of tumors, particularly for younger patients with a recurrent tumor burden.

Discussion: Symptomatic Neuroma Development following En Bloc Resection of Skeletal and Soft-Tissue Tumors: A Retrospective Analysis of 331 Cases

“…Discussion: Symptomatic Neuroma Development following En Bloc Resection of Skeletal and Soft-Tissue Tumors: A Retrospective Analysis of 331 Cases Floris V. Raasveld, MD 1,2 Kyle R. Eberlin, MD 3 Boston MA; and Rotterdam, the Netherlands S keletal and soft-tissue tumors often require resection with adjuvant radiation therapy and/or chemotherapy to achieve oncologic cure. During tumor extirpation, iatrogenic nerve injury of large or small nerves cannot always be avoided, potentially leading to development of symptomatic neuroma and neuropathic pain.…”

“…Although the prevalence in the amputee population has been estimated, the incidence and risk factors for symptomatic neuroma following oncologic resection have not been previously reported. 1 This study aimed to determine the incidence of symptomatic neuroma following tumor excision in more than 300 patients. Given the growing interest in the surgical approach for prevention and treatment of neuropathic pain, this topic has important practical implications for many reconstructive surgeons.…”